MAIN COMPANIES

Dense & high-quality industrial network

3rd largest cluster in France for healthcare & biotechnologies
- Over 800 companies
- 23,000 employees
- € 6.5 bn turnover

1st largest cluster in France for technical fabrics applied to healthcare

2nd largest cluster in France for medical and hospital equipment

Biotechnologies: Genfit, EFS – Etablissement Français du Sang, LFB – Laboratoire Français du Fractionnement et des Biotechnologies, Diagast, Cellial Technologies, Alz Protect, Intestinal Biotech Development, Endotis Pharma, Bifinove, …

Biomaterials: Cousin Biotech, Intech medical, Arthrex, …

Disinfection, Hygiene: Anios Laboratoires, Argos Hygiene, …

Fine chemicals / API: Ajinomoto, Calaire Chimie, Synthexim (Orgasynth group), Minakem, …

Traditional biotechnologies: Cargill, DSM Food Specialties, Lesaffre, Roquette, …

Pharmaceuticals & parapharmaceuticals: AstraZeneca, GSK Biologicals, Bayer Schering Pharma, DCI Pharma, Boiron, Dolisos, Minrad, Delpharm, Rottendorf Pharma, SuperDiet, Laboratoires Picot, Sarbec, Laboratoires TradiPhar, …

Medical Electronics and Electrics: Metrovision, Trato TLV, Biolume, Osyris, …

Health-applied technical textile: Cousin Biotech, Tyco Healthcare France, SCA Mölnlycke Healthcare, Inbrand, Prod’hygia, Hygiene Diffusion, …

Medical & Surgical equipment: Molnlycke Healthcare, Sterima, Lille Healthcare, Active Medical Disponables, MacoPharma, …

Latest investment decisions made by recognized leaders

Lille-Northern France major cluster in healthcare activities has been recently and strongly reinforced by major investment led by leaders in the fields of pharmaceutical and functional food:

Tate & Lyle announced a £3m (€4m) investment to establish a Wellness & Nutrition Centre in Lille, France. The centre, officially open in September 2008, includes laboratories and pilot plant facilities for customers. With a staff of more than 60 qualified people, this new center focuses on developing new ingredients in the field of wellness and nutrition, catering for beverage, dairy, bakery, and convenience food.

Bayer acquired Schering AG and the Berlin-based company was officially renamed Bayer Schering Pharma. The French headquarters of the new entity will soon open on the Eurasanté Bio-business park in Lille and will employ 800 people, 440 medical and pharmaceutical delegates and 360 people on-site.

GlaxoSmithKline Biologicals: GSK Bio, one of the world’s leading vaccine manufacturers, is investing more than 500 m € in its vaccine manufacturing plant in Saint Amand Les Eaux, Northern France, to increase production capacity in formulation, filling, freeze-drying and packaging, to meet growing worldwide demand for paediatric and adult vaccines. The new site, expected to be operational in 2011, will contribute to the production of many GSK’s innovative new vaccines.